Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Revenue | 112.63B | 14.43B | 103.47B | 96.50B |
| Cost of revenue | 40.22B | 39.49B | 40.40B | 43.73B |
| Gross profit | 72.40B | 65.81B | 63.06B | 52.77B |
| Research and development | 17.72B | 2.40B | 16.48B | 15.04B |
| Selling, general and administrative | 4.23B | 4.55B | 4.90B | 4.70B |
| Operating expenses | 36.57B | 4.96B | 35.35B | 33.14B |
| Operating income | 35.83B | 4.05B | 27.71B | 19.63B |
| Pre-tax income | 40.83B | 35.72B | 34.06B | 24.25B |
| Income tax | 6.03B | 5.46B | 4.70B | 5.03B |
| Net income | 33.76B | 4.07B | 29.42B | 20.34B |
| Earnings per share | 10.59 | 9.28 | 9.15 | 6.23 |
| Earnings per share, diluted | 10.48 | 9.19 | 9.05 | 6.17 |
| Weighted average shares | 3.19B | 3.20B | 3.22B | 3.26B |
| Weighted average shares, diluted | 3.22B | 3.23B | 3.25B | 3.30B |
| Metric | 19/08/2026 | 18/08/2026 | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 47.17B | 51.38B | 21.43B | — | — |
| Short-term investments | — | — |
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Operating cash flow | 50.74B | 39.68B | 35.33B | 27.71B |
| Depreciation and amortisation | 2.25B | 331M | 3.06B | 2.86B |
| Share-based compensation | 3.65B | 3.88B | 3.24B | 3.17B |
| Capital expenditure |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 22.80B |
| 1.47B |
| 4.44B |
| — |
| — |
| Receivables | — | — | 5.34B | 777M | 6.42B | — | — |
| Inventory | — | — | 689M | 78M | 695M | — | — |
| Current assets | — | — | 180.62B | 153.32B | 142.69B | — | — |
| Property, plant and equipment | — | — | 8.43B | 1.17B | 8.08B | — | — |
| Total assets | — | — | 221.42B | 195.99B | 185.92B | — | — |
| Current liabilities | — | — | 52.37B | 49.67B | 53.84B | — | — |
| Long-term debt | — | — | — | 428M | 428M | — | — |
| Total liabilities | — | — | 56.31B | 53.50B | 57.84B | — | — |
| Equity | — | — | 160.30B | 138.69B | 124.29B | 108.74B | 99.28B |
| Shares outstanding | — | — | 3.19B | 3.17B | 3.21B | — | — |
| Shares issued | — | — | 3.22B | 3.17B | 3.21B | — | — |
| 1.07B |
| 1.28B |
| 2.30B |
| 2.10B |
| Investing cash flow | −33.18B | 2.45B | −17.04B | −7.37B |
| Dividends paid | 13.83B | 11.17B | 8.01B | 6.72B |
| Financing cash flow | −20.16B | −27.34B | −21.47B | −10.24B |